
Researcher Verification
SOMA Research supplies research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are strictly for research use only — not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
For Research Purposes Only — This compound is not FDA approved.

Retatrutide (catalogue designation GLP-3 RT) is a 39-amino acid triple receptor peptide targeting the GLP-1, GIP, and glucagon pathways. Studied for metabolic-regulation and energy-balance signaling in research models. Premium Research Peptide.
Retatrutide, listed in this catalogue as GLP-3 RT, is a synthetic 39-amino-acid peptide with a molecular weight of about 4,731 g/mol. It is described in the literature as a triple agonist: a single molecule engineered to activate three related receptors, those for GIP, GLP-1 and glucagon. Dual agonists such as tirzepatide act on the first two; the glucagon receptor is what the third arm adds, and it is the reason the compound is studied separately rather than as a variation on earlier incretin peptides.
Three structural features do most of the work. The backbone is derived from the GIP sequence. Several positions carry non-coded amino acids, including two aminoisobutyric acid (Aib) residues, which protect the peptide from the DPP-4 enzyme that degrades native incretins within minutes. And a C20 fatty diacid is attached through a linker to a lysine side chain, so that the molecule binds serum albumin. That lipidation is what gives the compound its long residence time in pharmacokinetic studies, and it also changes how the material behaves on the bench.
This research-grade material is not that pharmaceutical product. It is not a medicine, has not been evaluated for safety in people, and is supplied for in vitro and laboratory work only. The retatrutide research guide covers the literature in depth, and retatrutide vs tirzepatide sets the triple and dual agonists side by side.
A 39-residue lipidated peptide with non-coded amino acids is a demanding synthesis, and the typical impurities are close relatives of the target: deletion sequences missing one residue, or species lacking the fatty-acid chain. That is why the Certificate of Analysis above reports more than one measurement. HPLC-UV purity shows how much of the peptide signal is the main peak. LC-MS identity confirms that the main peak has the mass of retatrutide rather than a near neighbour. Net peptide content gives the actual peptide mass in the vial, which is the number to use for concentration calculations, and the endotoxin result matters for any cell-based assay. HPLC vs mass spectrometry explains why neither method is sufficient alone, and how to read a Certificate of Analysis walks through each line.
Lipidated peptides behave differently from simple ones. The fatty-acid chain makes the molecule surface-active: it can adsorb to glass and plastic at low concentrations, and it foams if shaken. Reconstitute by letting the solvent run down the vial wall and swirling gently. Keep the lyophilised powder frozen, dry and away from light; once in solution, refrigerate, use within weeks, and divide into single-use aliquots instead of freezing and thawing a stock repeatedly. For very dilute working solutions, low-binding tubes reduce losses to the container. See peptide storage and stability and how to reconstitute a research peptide.
Yes. GLP-3 RT is the catalogue designation used on this site for retatrutide, CAS number 2381089-83-2. The LC-MS identity result on the Certificate of Analysis confirms the molecular mass for each lot.
Because the single peptide activates three receptors in in vitro assays: the GIP receptor, the GLP-1 receptor and the glucagon receptor. Dual agonists such as tirzepatide act on the first two only.
No. Clinical trials use pharmaceutical-grade product manufactured under GMP by the originator. This is research-grade material for in vitro and laboratory use only. It is not a medicine and is not for human or veterinary use.
It is a lipid chain attached to a lysine side chain through a linker. It lets the peptide bind serum albumin, which extends its residence time in pharmacokinetic studies. On the bench it also makes the peptide surface-active, so it can foam and adsorb to container walls.
Keep the lyophilised powder at -20 C, dry and protected from light. After reconstitution store at 2-8 C, avoid repeated freeze-thaw cycles and aliquot into single-use volumes where the protocol allows.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, you confirm that you are a qualified researcher and will use these products in accordance with all applicable laws and regulations.